The TissueCyte 1000 is the world’s only system engineered specifically for fully automated whole organ imaging. In as little as four hours, and without any user intervention, the TissueCyte produces 3D images of entire ex-vivo organs with micron resolution and beyond.

Unlike traditional CT systems, the fluorescence-based TissueCyte is ideal for high-throughput studies of transgenic animals labeled with fluorescent proteins.  By the nature of its patented method of alternating mechanical sectioning with high-speed multi-photon microscopy, the TissueCyte produces pristine datasets, which, with only minimal post-processing, readily morph onto to MRI datasets or standard anatomical atlases.
 
The TissueCyte 1000 is suitable for individual investigators, research centers and commercial laboratories.  Installed to customers throughout the world, the TissueCyte is a proven, robust system for continuous 24/7 operation in production environments.  

Email info@tissuevision.com for more information and a quotation.

Jan 2010: TissueVision was awarded a Phase I Small Business Innovation Research (SBIR) grant to develop a novel angiogenesis assay.

August 2008: TissueVision is featured on the cover of the August issue of BioOptics World

May 2008: TissueVision was awarded a Phase I Small Business Innovation Research (SBIR) grant to develop a novel time resolved spectroscopy detection method for fluorescence lifetime and tissue photon migration studies.

October 2005: TissueVision was awarded a Phase II Small Business Innovation (SBIR) grant from the NIH for the development of its high speed multispectral tissue imaging technology.

May 2005: TissueVision was selected as a Finalist in the MIT $100K Business Plan competition.